Home
NSE: AUROPHARMA
YEARLOW
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
01 Feb 2025 | 1143 |
31 Jan 2025 | 1171.75 |
30 Jan 2025 | 1182.35 |
29 Jan 2025 | 1156.9 |
28 Jan 2025 | 1137.75 |
27 Jan 2025 | 1175.3 |
24 Jan 2025 | 1211.85 |
23 Jan 2025 | 1245.3 |
22 Jan 2025 | 1191.2 |
21 Jan 2025 | 1186.7 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Aurobindo Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Aurobindo Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
16 Aug 24
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
16 Aug 24
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
12 Aug 24
The approved drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD)
Read more
07 Aug 24